Literature DB >> 28891209

Blood component transfusions in mass casualty events.

G Ramsey1,2,3.   

Abstract

BACKGROUND AND OBJECTIVES: Planning transfusion needs in mass casualty events (MCE) is critical for disaster preparedness. Published data on blood component usage were analysed to seek correlative factors and usage rates.
MATERIALS AND METHODS: English-language medical publications since 1980 were searched for MCEs with numbers of patient admissions and transfused RBCs. Reports were excluded from natural disasters or with total RBC use <50 units. Statistical analysis employed Mann-Whitney U-tests and Spearman's rank correlations.
RESULTS: In 24 reports, the average units per admission were 3·06 RBCs, 2·13 plasmas and 0·37 platelet doses. Five RBCs per admission would have sufficed for 87% of events. Transfusion needs involving bombings correlated with admissions (P ≤ 0·03). In the formula (massive-transfusion patients in MCE) times X = (total units for all MCE patients), the average X was 35 for RBCs (correlation P = 0·01), 17 for plasma (P = 0·10) and five for platelet doses (P = 0·06). From 67% to 84% of all components used were given in the first 24 h (event medians).
CONCLUSIONS: Blood component use in MCEs correlated with numbers of patients admitted or receiving massive transfusion. More current data are needed to better reflect emerging trauma care practices and refine predictive models of transfusion needs.
© 2017 International Society of Blood Transfusion.

Entities:  

Keywords:  blood components; massive transfusion; transfusion medicine (in general); transfusion-trauma

Mesh:

Year:  2017        PMID: 28891209     DOI: 10.1111/vox.12564

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  2 in total

1.  Emergency preparedness, resilience and response guidance for UK hospital transfusion teams.

Authors:  Heidi Doughty; Fateha Chowdhury
Journal:  Transfus Med       Date:  2020-02-04       Impact factor: 2.019

2.  Limitations of Available Blood Products for Massive Transfusion During Mass Casualty Events at US Level 1 Trauma Centers.

Authors:  James Williams; Michael Gustafson; Yu Bai; Samuel Prater; Charles E Wade; Oscar D Guillamondegui; Mansoor Khan; Megan Brenner; Paula Ferrada; Derek Roberts; Tal Horer; David Kauvar; Andrew Kirkpatrick; Carlos Ordonez; Bruno Perreira; Artai Priouzram; Juan Duchesne; Bryan A Cotton
Journal:  Shock       Date:  2021-12-01       Impact factor: 3.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.